In this week’s edition of InnovationRx, we look at the opportunities and challenges of using AI to personalize healthcare and speed up clinical trials, the future of genetic medicine, another big Lilly acquisition, and more.
Comparing Tesla and Rivian stock in 2026? See the analysis of these two companies to find the better investment for your portfolio needs.
This week’s Current Climate newsletter also looks at whether urbanists should embrace robotaxis and how the Middle East war may impact the renewable energy transition
Solving a century-old mystery about rubber. The space economy keeps booming. The physics of stir fry. All that and more in this week’s edition of The Prototype.
Formation Bio CEO Ben Liu is convinced that drug discovery isn’t the bottleneck in getting medicines to market—it’s going through clinical trials. Now he’s raised some $615 million from top investors to buy stalled drugs and use AI to stress test them …
AI’s New Training Data: Your Old Work Slacks And Emails
After watching engineers burn out from fixing late-night outages, Resolve AI CEO Spiros Xanthos is developing AI systems to ease the burden of being on call, backed by a new $40 million funding round.
Paris-based Mistral wanted to develop a top-tier AI model to rival OpenAI and Anthropic. That didn’t work out. But it turns out lots of folks don’t care if the AI is bleeding edge – as long as it wasn’t made in America or China.
Forbes’ AI 50 list spotlights the most promising privately held companies applying artificial intelligence to solve real-world challenges.
The Middle East conflict, coupled with rising electricity usage due to AI, is boosting demand for energy storage products such as those from China’s Sigenergy Technology. The investor optimism has made founder Xu Yingtong a billionaire with a net worth…